Brem, H., Golinko, M. S., Stojadinovic, O., Kodra, A., Diegelmann, R. F., Vukelic, S., . . . Tomic-Canic, M. (2008). Primary cultured fibroblasts derived from patients with chronic wounds: A methodology to produce human cell lines and test putative growth factor therapy such as GMCSF. BioMed Central.

Brem, Harold, Michael S. Golinko, Olivera Stojadinovic, Arber Kodra, Robert F. Diegelmann, Sasa Vukelic, Hyacinth Entero, Donald L. Coppock, and Marjana Tomic-Canic. Primary Cultured Fibroblasts Derived From Patients With Chronic Wounds: A Methodology to Produce Human Cell Lines and Test Putative Growth Factor Therapy Such As GMCSF. BioMed Central, 2008.

Brem, Harold, et al. Primary Cultured Fibroblasts Derived From Patients With Chronic Wounds: A Methodology to Produce Human Cell Lines and Test Putative Growth Factor Therapy Such As GMCSF. BioMed Central, 2008.